Institutional Biosafety Committee
The NIH Institutional Biosafety Committee (IBC) provides recommendations to the Director of the NIH or his designee, in matters pertaining to the control of hazards associated with the intramural use of microbiological agents, their vectors, and recombinant DNA. The committee serves as an advisory body to the Division of Occupational Health and Safety (DOHS), Office of Research Services (ORS).
Recombinant DNA and Pathogen Registration submissions are submitted electronically through the
PI Dashboard system. Please check the
NIH: IBC Meeting and Deadline Dates for 2021 - IBC Meeting and Deadline Dates For Submission for the IBC meeting schedule and deadlines.
Read more from the Charter for the NIH Institutional Biosafety Committee.
|Harry L. Malech
|Richard G. Baumann||Biological Safety Officer, Voting Contact|
|Committee Member, Clinician|
Deborah A. Michaels
Senior Research Associate
Scientific Technical Writer
|Associate Biological Safety Officer|
|Jeremy L. Davis||Committee Member, Clinician|
Stephen L. Denny
Animal Expert, Animal Program Director
Stephanie M. Goff
|Steve S. Whitehead||Committee Member, Virologist|